| Single-dose psilocybin for a treatment-resistant episode of major depression GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ... New England Journal of Medicine 387 (18), 1637-1648, 2022 | 436 | 2022 |
| The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous … JJ Rucker, L Marwood, RLJ Ajantaival, C Bird, H Eriksson, J Harrison, ... Journal of psychopharmacology 36 (1), 114-125, 2022 | 63 | 2022 |
| Psilocybin and MDMA for the treatment of trauma-related psychopathology CIV Bird, NL Modlin, JJH Rucker International Review of Psychiatry 33 (3), 229-249, 2021 | 58 | 2021 |
| Historic psychedelic drug trials and the treatment of anxiety disorders NM Weston, D Gibbs, CIV Bird, A Daniel, LA Jelen, G Knight, D Goldsmith, ... Depression and Anxiety 37 (12), 1261-1279, 2020 | 36 | 2020 |
| The pharmacological interaction of compounds in ayahuasca: a systematic review S Ruffell, N Netzband, C Bird, AH Young, MF Juruena Brazilian Journal of Psychiatry 42, 646-656, 2020 | 32 | 2020 |
| The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls W Lawn, C Mokrysz, R Lees, K Trinci, K Petrilli, M Skumlien, A Borissova, ... Journal of psychopharmacology 36 (12), 1350-1361, 2022 | 26 | 2022 |
| Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial J Rucker, H Jafari, T Mantingh, C Bird, NL Modlin, G Knight, F Reinholdt, ... BMJ open 11 (12), e056091, 2021 | 14 | 2021 |
| Psilocybin administration to healthy participants: Safety and feasibility in a placebo-controlled study J Rucker, A Young, C Bird, A Daniel, M Lennard-Jones, L Marwood, ... Reflections 4 (3), 2, 2019 | 12 | 2019 |
| Clinical characteristics and impacts of HIV infection in people with bipolar disorders N Yalin, I Conti, S Bagchi, A Essig, C Bird, K Adlington, IP Everall, ... Journal of Affective Disorders 294, 794-801, 2021 | 2 | 2021 |
| The effects of COMP360 (psilocybin formulation) on cognitive function: Results from a randomized, placebo-controlled trial in healthy participants J Rucker, A Young, C Bird, J Harrison, L Marwood, S Mistry, S Stansfield, ... J. Psychopharmacol 36 (1), 114-125, 2021 | 1 | 2021 |
| Springtime for psychopharmacology C Bird, AH Young Journal of Psychopharmacology 36 (3), 249-251, 2022 | | 2022 |
| " The pharmacological interaction of compounds in ayahuasca: A systematic review": Corrigendum. S Ruffell, N Netzband, C Bird, AH Young, MF Juruena Associação Brasileira de Psiquiatria, 2020 | | 2020 |
